O. Hursitoglu Et Al. , "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients," Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121, 2023
Hursitoglu, O. Et Al. 2023. Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121 .
Hursitoglu, O., Kurutas, E. B., Strawbridge, R., Oner, E., Gungor, M., TUMAN, T. C., ... UYGUR, Ö. F.(2023). Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121.
Hursitoglu, Onur Et Al. "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients," Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121, 2023
Hursitoglu, Onur Et Al. "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients." Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121, 2023
Hursitoglu, O. Et Al. (2023) . "Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients." Progress in Neuro-Psychopharmacology and Biological Psychiatry , vol.121.
@article{article, author={Onur Hursitoglu Et Al. }, title={Serum NOX1 and Raftlin as new potential biomarkers of Major Depressive Disorder: A study in treatment-naive first episode patients}, journal={Progress in Neuro-Psychopharmacology and Biological Psychiatry}, year=2023}